Takara Bio USA collaborates with Illumina on a single-cell-resolution spatial mapping workflow, presented at AGBT 2026.

Touch—the first sense to develop in the womb—is fundamental to our bodily experience and our everyday lives. Yet, as the ...

Researchers identified invasive early disseminated cancer cells and immunosuppressive macrophage signaling that promote ...

This is not incremental progress - it is a step-change that unlocks industrial-scale biology for drug discovery, toxicology, and AI-driven research. Our additional investment reflects our conviction ...

Are you attending the ABRF Annual Meeting 2026? Here are the breakout sessions and workshops you won’t want to miss.

Illumina, Inc. (NASDAQ: ILMN) announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, ...

Studying gene expression in a cancer patient's cells can help clinical biologists understand the cancer's origin and predict the success of different treatments. But cells are complex and contain many ...

The collaborations will provide Illumina's customers with workflows for genomic disease characterization and spatial mapping.

Figuring out who to screen could change the game. This discovery is getting us closer.

TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data demonstrates its accuracy in detecting rare genetic diseases40% increase in output to ...

Recent advancements in systems biology have been propelled by the increasing power of omics technologies—spanning genomics, transcriptomics, proteomics, ...

Published as an arXiv preprint, the paper details how unsupervised and self-supervised AI models are matching or surpassing ...